Regenerating neural tissue. Restoring function.
-
Based on strong scientific rationale with an excellent safety profile
-
NAION-first with extensive pipeline
-
Led by healthcare veterans turned visionaries
We are Regenera
Regenera Pharma is on a mission: to help patients restore the function lost to neurological diseases. We are making great strides in that direction. Our growing scientific evidence shows that our lead drug candidate has regenerative activity and functional recovery benefits.
-
Lead Drug Candidate
RPh201, is a botanical drug based on purified active constituents of the Mastic gum, a plant that has been used in health care for centuries. Data shows that RPh201 stimulates synaptogenesis and neurogenesis.
Read on > -
Clinical Program
We are about to start our Phase 3 study in patients with NAION, a stroke of the optic nerve that affects more than 200,000 people in the U.S. alone, and a Phase 2 study in Alzheimer’s disease patients.
Read on >